Media:
media@abogenbio.com
media@abogenbio.com
-
2021-08-19Abogen Biosciences Secures Over $700 Million in Series C Financing to Accelerate its mRNA Platform Across Multiple Vaccines and Diverse Therapeutic Fields -
2021-04-07Abogen Biosciences Closes ¥600 Million Series B Financing
-
2020-10-27Abogen Biosciences Closes ¥150 Million Series A Financing
-
2020-06-19Abogen Biosciences' First mRNA Vaccine Got Approval for Clinical Trials